Colgate-Palmolive (India) Ltd (COLPAL) Q1 FY27 Results Analysis: Revenue Grows 12%, Margin Compresses 150 bps

CompoundingAI Research Updated July 29, 2026 2 min read
Neutral

Colgate-Palmolive (India) Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,590.56 Cr (+11.96% YoY) and PAT growth of +7.01% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 29, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 1,590.56 Cr (+11.96% YoY)
PAT (Q1)Rs. 343.08 Cr (+7.01% YoY)
EBITDA margin30.36% (-150 bps YoY)
EPS (Q1)Rs. 12.61 (+6.96% YoY)
Market capRs. 58,914.83 Cr
CMPRs. 2,166.05

Quarter Snapshot

Revenue grew 12% YoY, the fastest in two years, driven by high-single digit volume growth and premium toothpaste. However, EBITDA margin compressed 150 bps YoY due to a sharp advertising step-up (33.7% YoY) and raw material cost inflation (up 25% YoY). PAT growth lagged at 7%. The company is investing for growth, but near-term margin headwinds are significant.

Key Investment Insights

Key Positives

  • Net sales grew 11.96% YoY to Rs.1,590.56 Cr, the fastest quarterly growth in at least two years.
  • High-single digit volume growth in toothpaste portfolio, driven by premium segment.
  • Gross margin at 69.73% came in slightly above the guided range of 69.3-69.6%.
  • Management confirmed volume-driven growth priority and stepped up advertising to support premiumization.

Risk Factors

  • EBITDA margin compressed 150 bps YoY to 30.36% and 184 bps QoQ.
  • Advertising spend jumped 33.68% YoY to Rs.251.86 Cr, representing 15.83% of net sales, pressuring margins.
  • Cost of materials consumed surged 25.18% YoY due to commodity inflation and rupee depreciation.
  • PAT growth of 7.01% YoY lagged revenue growth of 11.96%, reflecting margin compression.
  • Exceptional items of Rs.3.34 Cr for GST inverted duty structure and restructuring costs.
  • Forex headwind from rupee depreciation (~2.1% QoQ) impacted material costs.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now